How to Get Started with Tirzepatide Weight Loss Injections Before you begin tirzepatide injections, consult with a medical provider
Clinical trials show semaglutide produces an average of ~15% body weight loss at 68 weeks, while tirzepatide has demonstrated up to 20.9% weight loss at 72 weeks. Patients in our medical weight loss program which include nutrition and muscle preservation support lose an average of 1520% of their excess body weight on injectable GLP-1 medications, which is clinically meaningful and can improve conditions like type 2 diabetes, high blood pressure, and sleep apnea
Following the announcement of positive trial results, share prices of various device makers in the diabetes (including insulin pump makers such as Insulet and glucose monitor makers such as DexCom) and chronic kidney disease (e.g
Footnotes 1.^Press release Boehringer Ingelheim, February 19, 2019
GLP-1 stands for glucagon-like peptide-1, a naturally occurring hormone involved in blood sugar regulation, insulin response, digestion, and appetite control
Reconstitution Fluid: When preparing the sample for assay analysis, gently introduce bacteriostatic water or sterile normal saline down the inner glass wall of the vial
